Irene Garcia-Cadenas

24PUBLICATIONS
109CO-AUTHORS
Haematological tumoursMajor global burdens of diseaseMolecular targetsRadiation therapyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 04, 2026
Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.

|Jan 08, 2026
Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC Study.

Irene García-Cadenas, Manuel Guerreiro, Lucrecia Yañez

|Jan 22, 2025
HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma.

Ana Carolina Caballero, Cristina Ujaldón-Miró, Paula Pujol-Fernández

|Dec 11, 2024
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC.

Virginia Escamilla-Gómez, Valentín García Gutiérrez, Patricia Alcalde-Mellado

|Nov 15, 2024
Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized Treatment.

Sara Redondo, María Costa, Maria-Estela Moreno-Martinez

|Aug 19, 2024
Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantation.

Sara Redondo, Irene García-Cadenas, Albert Esquirol

Pageof 4

Frequent Collaborators

11 joint publications

Rodrigo Martino Bofarull

9 joint publications

Albert Esquirol

6 joint publications

Silvana Novelli

5 joint publications

Sierra Jorge